Why Integrral Media:

The Awardees will have to pass through 3 tier process by mail, sms poll & jury’s verdict. Malvinder Mohan Singh, Chairman, Fortis Group & parkway Holdings, Ajay Piramal,Chairman Nicholas Piramal, Dilip Sanghvi,Sun Pharmaceutical Industries Ltd are the top contenders of Businessman of the year, while Pfizer, Sun, Ranbaxy,Lupin are for Company of the year – Best Company in R&D Excellence – Glenmark, Bharat Biotech., Dynamic Entrepreneur of The Year – Satish Reddy of Dr Reddy’s Labs, Dr Krishna Ella of BBIL, Dilip Surana of Microlabs, Nikunj Kanakia of Lifeline Pharma. Emerging Company of The Year. India’s Most Admired Pharma Company. Research Scientist of The Year. Excellence in Bulk Drugs & Exports. , Hottest Exports Company of the Year. Company of the year ( SME). India’s Most Watched Company of the year. Excellence in Nutrition & Nutraceuticals Abott Nutrition, British Biologicals, Dr Anjali Mukerjee’s Health Total. ,Best Product Launch of the year. Excellence in Pharmacy & Community Healthcare profession. India’s Most Advanced Manufacturing Company. OTC Pharma Company of the year – Alkem Health Foods, Ajanta Pharma, Ranbaxy,Abott Nutrition . Businesswoman of the year – Kiran Majumdar Shaw of Biocon, Dr Swati Piramal of Nicholas Piramal & Dr Dr. Villoo Morawala-Patell of Avesthagen. Lifetime Achievement Award 2010. Brand of The Year – REVITAL, TAXIM , BECOSULE. Pharma Professional of the Year – Tapan Ray of OPPI & Kewal Handa of Pfizer.Ngo of the year – Wockhardt Foundation, Salman Khan’s Being Human Foundation, Cry. India’s Most admired Surgeon – Dr Ramakant Panda of Asian Heart Institute. India’s Fastest growing Retail Chain – Trust Chemists & Druggists Ltd.

Originally launched in 1999 as the Pharma Business & Technology Excellence Awards, these were first produced by the PHARMA BUSINESS & TECHNOLOGY MAGAZINE as a means of honoring innovation in pharmaceutical marketing, corporate governance and research and development & Lifetime Achievements category. Pharma Excellence Awards were produced by PBT Awards in India and expanded to recognize global corporate citizenship and individual achievements.As PBT Magazine was discontinued, the task was taken up by the Management of Pharma Leaders Magazine. Over the Years, the awards was re-evaluated and recast to focus more on scientific accomplishments in industry and academic pharmaceutical research. The awards have been presented and at a sold-out black tie gala to over 50 industry executives and leading academic scientists from around the world joined in a moving tribute to the more than twenty winners honored that evening. PRVIOUS AWRAD WINNERS : Late Shri Parvinder Singh, Ranbaxy –Chairman, Ranbaxy Labs Ltd, 1999, Shri Desh Bandhu Gupta,Chairman, Lupin Ltd – 1999, Shri K.Anji Reddy, Chairman, Dr Reddy’s Labs Ltd – 1999, Shri Devinder Pal, Management Consultant. 1999, Shri Samprada Singh, Chairman, Alkem Labs Ltd., Shri Ajit Singh, Chairman, ACG Worldwide, Shri I.A.Modi, Chairman, Cadila Pharmaceuticals Ltd. Shri Vikram Aima, CMD, Ochoa Labs Ltd. Shri Habil F Khorakiwala.Chairman, Wockhardt Ltd. Shri Raghavendra Rao, Chairman, Orchid Pharmaceuticals Ltd. Shri Dilip Sanghvi, CMD, Sun Pharmaceuticals Ltd. The 2010 annual Pharmaceutical Achievement Awards recognize the significant accomplishments of individuals and organizations in the global pharmaceutical and biotechnology industries in the areas of science, business and corporate generosity. These awards have been designed with the broad support and unbiased contributions of industry and academic advisors, a well respected international accounting firm and the production team of Pharma Leaders under the supervision of Editor-In-Chief of Pharma Leaders Magazine.

Message :


New Faces for a New Pharma
When talking about pharmaceutical leadership, “transformational” is the descriptor of choice. With the regulatory landscape evolving rapidly, traditional pharma cocompanies taking the plunge into biotechnology and specialty medicine, and the lifespan of products shrinking, leaders are needed who can push changes in their organizations and within the pharmaceutical industry. To determine who are today’s executives on the rise, Pharmaceutical Leadership Summit 2010 sought the agents of change within the industry, the executives who are helping to take their companies in new and different directions.

Agents of change are appearing throughout organizations. Starting at the back of the value chain are the research and development transformers, who are taking an accelerated, disease-centric approach to R&D versus a therapeutic area approach. Further up are the commercial transformers, changing their organizations’ approach to sales and marketing. And then there are the medical transformers, who are focused on more effectively moving drugs from the late stages of clinical development to the patient.On the commercial front, a trend can be seen among the industry’s executives on the rise. These individuals acting as agents of change have all been brought in from outside the company with a clear charge to transform the business. In some cases, these companies are clearly looking to organize around key specialty pharma business units. These are also individuals with strong U.S. and European experience.Patient access has become more critical than ever before. As a result, the pharmaceutical industry has seen a move toward creating the function of chief medical officer and empowering medical affairs in a different manner than the traditional brand support of previous years. The goal of the chief medical officer is to look holistically at drug development, getting the drug first into the hands of the prescribers, and then into the hands of the patients.

A number of underlying, evolutionary trends are changing the very nature of how the pharmaceutical industry operates and the talent the industry requires. These changes affect the views, practices, and needs of the people the industry employs and the markets and patients the industry serves. The retained executive search firm Heritage Partners International interviewed a range of human resources executives from bioThe pharmaceutical market in India was a surprise gift to the industry in 2005. Since the Indian government had eliminated product patents, introduced high tariffs and limits on imported medicines, and demanded that foreign pharmaceutical companies reduce their shares in their Indian subsidiaries to two-fifths in the early 1970’s, pharmaceuticals in the world’s second most-populous country had for many years been dominated by domestic players manufacturing branded generics. With India’s signature of the World Trade Organization’s Agreement on Trade Related Aspects of Intellectual Property Rights, though, the country was required to bring its IP protection policies into line with other signatories, and the Indian Patents Amendment Act of 2005 duly restored product patentstech and pharma organizations to discover their views on the most important of these changes, how they have shaped the environment in which they operate, and how their global organizations are preparing to remain successful in their respective businesses, particularly in building the necessary teams.

Pharmaceutical executives are well aware that commercial strategies of the last decade are losing effectiveness. At the root of the problem is a profitability-draining commercial cost basis, which results from a sales model that is often overly focused on the primary-care physician. The short-term solution – cutting back on field sales forces – has taken companies about as far as it can. Pharmaceutical companies urgently need a new commercial approach that will either reduce their investment in the commodity segment or shift it to other segments that will deliver better returns. Additionally, to achieve meaningful change, companies will have to rethink not only how they bring their products to market, but also what they bring to the market.

Under the changed scenario,3rd Annual Pharmaceutical Leadership Summit 2010 will dwell upon many more issues by industry veterans.....on topics of great importance. I urge you to attend the high profile event.

Looking forward to see you...

Chairman - Pharmaceutical Leadership Summit 2010